Patent Portfolio Litigation Funding: Systematic IP Monetization

How funders structure capital across patent portfolios, manage PTAB risk, and weigh licensing against litigation.

Patent portfolio litigation funding finances the systematic monetization of a collection of related patents, rather than a single assertion. A company or inventor holding a portfolio of patents covering a technology can pursue value through licensing campaigns, litigation against multiple infringers, or structured sale, and funding provides the capital to execute these strategies across the portfolio. Portfolio structures diversify the risk that any single patent is invalidated or any single case lost, which improves the risk profile relative to financing one assertion.

The diversification benefit is central to the portfolio approach. A single patent case carries binary risk: an adverse claim construction, a successful invalidity challenge, or a defense verdict can eliminate its value. A portfolio campaign against multiple defendants, or across multiple patents, spreads that risk, so that one adverse outcome does not destroy the entire investment. Funders structure portfolio deals so that capital covers assertion costs across the portfolio and the return is tied to aggregate performance rather than any one case.

PTAB risk remains the dominant concern even at the portfolio level. Each asserted patent is vulnerable to inter partes review, and defendants frequently petition to invalidate the claims being asserted against them. A portfolio with several strong, IPR-resistant patents is far more valuable than one resting on a single patent of uncertain validity. Funders assess the validity and IPR exposure of the key patents in the portfolio, recognizing that the campaign's value depends on patents that can survive administrative challenge.

The strategic choice between licensing and litigation shapes the economics. A portfolio holder may prefer to license its patents, generating recurring revenue without the cost and risk of litigation, but litigation or its credible threat is often necessary to bring reluctant infringers to the table. Funders evaluate the assertion strategy, the strength of the portfolio, the universe of potential licensees or defendants, and the realistic licensing and litigation outcomes when structuring capital for a monetization campaign.

Criterica Capital funds patent portfolio monetization, assessing portfolio validity and IPR exposure against outcome data drawn from 106M+ court records, including PTAB and patent litigation history. This grounds our underwriting of these campaigns in observed outcomes. Patent holders and their counsel can contact our institutional team to discuss portfolio funding structures.

Discuss your matter with our institutional team.